Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Cited by 181

The DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.

Impact of aggressive management and palliative care on cancer costs in the final month of life

Open access
Cheung, Matthew C., Earle, Craig C., Rangrej, Jagadish, Ho, Thi H., Liu, Ning, Barbera, Lisa, Saskin, Refik, Porter, Joan, Seung, Soo Jin, Mittmann, Nicole · 2015 · Cancer

Abstract

BACKGROUND: A significant share of the cost of cancer care is concentrated in the end‐of‐life period. Although quality measures of aggressive treatment may guide optimal care during this timeframe, little is known about whether these metrics affect costs of care. METHODS: This study used population data to identify a cohort of patients who died of cancer in Ontario, Canada (2005‐2009). Individuals were categorized as having received or having not received aggressive end‐of‐life care according to quality measures related to acute institutional care or chemotherapy administration in the end‐of‐life period. Costs (2009 Canadian dollars) were collected over the last month of life through the linkage of health system administrative databases. Multivariate quantile regression was used to identify predictors of increased costs. RESULTS: Among 107,253 patients, the mean per‐patient cost over the final month was $18,131 for patients receiving aggressive care and $12,678 for patients receiving nonaggressive care (P < .0001). Patients who received chemotherapy in the last 2 weeks of life also sustained higher costs than those who did not (P < .0001). For individuals receiving end‐of‐life care in the highest cost quintile, early and repeated palliative care consultation was associated with reduced mean per‐patient costs. In a multivariate analysis, chemotherapy in the 2 weeks of life remained predictive of increased costs (median increase, $536; P < .0001), whereas access to palliation remained predictive for lower costs (median decrease, $418; P < .0001). CONCLUSIONS: Cancer patients who receive aggressive end‐of‐life care incur 43% higher costs than those managed nonaggressively. Palliative consultation may partially offset these costs and offer resultant savings. Cancer 2015;121:3307–3315. © 2015 American Cancer Society.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1002/cncr.29485

Cites

7 of 7 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 7 references

Cited by

See all 181

Metadata

Authors
Cheung, M. C., Earle, C. C., Rangrej, J., Ho, T. H., Liu, N., Barbera, L., Saskin, R., Porter, J., Seung, S. J., & Mittmann, N.
Venue
Cancer
Publisher
Wiley
Published
2015-05-29
Volume
121
Issue
18
Pages
3307-3315
ISSN
  • 0008-543X (ISSN-L)
  • 1097-0142
OpenAlex
W1500612359
Cited by
181
References
7
FWCI
14.23
Type
journal article
Language
en
Open access
hybrid

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Impact of aggressive management and palliative care on cancer costs in the final month of life. https://app.cochat.ai/papers/10.1002/cncr.29485
The paper
Cheung, M. C., Earle, C. C., Rangrej, J., Ho, T. H., Liu, N., Barbera, L., Saskin, R., Porter, J., Seung, S. J., & Mittmann, N. (2015). Impact of aggressive management and palliative care on cancer costs in the final month of life. Cancer. https://doi.org/10.1002/cncr.29485

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.